NCT03024996 · Interventional trial
A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy
Overall registry status Terminated
Phase 3
Conditions Renal Cell Carcinoma
Delaware Valley sites
- Fox Chase Cancer Center; Hematology/Oncology · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory